首页/数据集/Analysis of relative risk of poor neutralizing response to COVID-19 vaccination in dialysis patients.

Analysis of relative risk of poor neutralizing response to COVID-19 vaccination in dialysis patients.

NIAID Data Ecosystem2026-03-13 收录

数据链接：

https://figshare.com/articles/dataset/Analysis_of_relative_risk_of_poor_neutralizing_response_to_COVID-19_vaccination_in_dialysis_patients_/19157050 数据链接链接失效反馈

官方服务：

资源简介：

Analysis of relative risk of poor neutralizing response to COVID-19 vaccination in dialysis patients.

应用场景：

创建时间：

2022-02-10

血液透析患者免疫

T细胞衰老预测模型

Patients with end-stage renal disease (ESRD) are at high risk of morbidity and mortality from cardiovascular and infectious diseases, which have been found to be associated with a disturbed immune res

NIAID Data Ecosystem40

Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study

COVID-19疫苗有效性评估

变异株临床风险分析

To assess the risk of severe clinical outcomes, to identify risk factors for severe clinical outcomes among persons with SARS-CoV-2 infection and persons with varying vaccination status for COVID-19 d

DataCite Commons2022-12-21 更新30

Table_10_A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.docx

COVID-19疫苗有效性评估

加强免疫策略分析

It is urgently needed to update the comprehensive analysis about the efficacy or effectiveness of COVID-19 vaccines especially during the COVID-19 pandemic caused by SARS-CoV-2 Delta and Omicron varia

NIAID Data Ecosystem20

Table_1_Chronic Inflammation Might Protect Hemodialysis Patients From Severe COVID-19.pdf

血液透析患者免疫

COVID-19疾病严重程度

Hemodialysis patients (HD) are expected to have excess mortality in coronavirus disease 2019 (COVID-19). This was challenged by a recent study reporting HD patients to have comparable mortality and le

NIAID Data Ecosystem30

Table_1_Evaluation of COVID-19 vaccines in primary prevention against infections and reduction in severity of illness following the outbreak of SARS-CoV-2 omicron variant in Shanghai.pdf

COVID-19疫苗有效性评估

奥密克戎变异株

ObjectivesTo evaluate COVID-19 vaccines in primary prevention against infections and lessen the severity of illness following the most recent outbreak of the SARS-CoV-2 Omicron variant in Shanghai. Da

NIAID Data Ecosystem20

Analysis of relative risk of poor neutralizing response to COVID-19 vaccination in dialysis patients.

资源简介：

相关数据集